ACN Form 144: Proposed sale of 6,902 shares ($1,725,500)

ACN: A shareholder filed a Form 144 notice to sell up to 6,902 Class A Ordinary shares, with an aggregate market value of $1,725,500.

Rhea-AI Filing Summary

ACN: A shareholder filed a Form 144 notice to sell up to 6,902 Class A Ordinary shares, with an aggregate market value of $1,725,500. UBS Financial Services is listed as broker, and the approximate sale date is 10/22/2025 on the NYSE.

The shares were acquired via stock awards on 11/15/2024 (19), 02/14/2025 (8), and 10/20/2025 (6,875). Shares outstanding were 658,171,748; this is a baseline figure, not the amount being offered.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did ACN’s Form 144 disclose?

A shareholder filed a notice to sell up to 6,902 Class A Ordinary shares with an aggregate market value of $1,725,500.

Which broker is handling the proposed sale for ACN shares?

The filing lists UBS Financial Services as the broker.

When might the ACN shares be sold under this Form 144?

The filing shows an approximate sale date of 10/22/2025.

On which exchange are the ACN shares listed?

The shares are listed on the NYSE.

How were the ACN shares being sold acquired?

They were acquired via stock awards on 11/15/2024 (19), 02/14/2025 (8), and 10/20/2025 (6,875).

How many ACN shares are outstanding?

The filing lists 658,171,748 shares outstanding.

Is this a large sale relative to ACN’s share count?

The notice covers 6,902 shares versus 658,171,748 outstanding, indicating a small size relative to the total.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/22/2025 - 04:05 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001911109
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Accenture plc
SEC File Number	001-34448
Address of Issuer	1 GRAND CANAL SQUARE GRAND CANAL HARBOUR DUBLIN IRELAND D2
Phone	353-1-646-2000
Name of Person for Whose Account the Securities are To Be Sold	Sharma Manish
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A Ordinary	UBS Financial Services, Inc. 11 Madison Ave 4th Floor New York NY 10010	6902	1725500.00	658171748	10/22/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A Ordinary	10/20/2025	Stock Award	Issuer			6875	10/20/2025	N/A
Class A Ordinary	11/15/2024	Stock Award	Issuer			19	11/15/2024	N/A
Class A Ordinary	02/14/2025	Stock Award	Issuer			8	02/14/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	10/22/2025
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/24/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ UBS Financial Services Inc, as attorney-in-fact for Manish Sharma
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)